Simplex Trading, LLC Stoke Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$3.28 Billion
Q4 2024

A detailed history of Simplex Trading, LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,481 shares of STOK stock, worth $12,010. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,481

Previous 2,638 43.86%

Holding current value

$12,010

Previous $32,000 50.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$10.8 - $13.92 $12,495 - $16,105	-1,157 Reduced 43.86%	1,481 $16,000
Q3 2024 Nov 08, 2024	SELL	$12.24 - $15.92 $25,569 - $33,256	-2,089 Reduced 44.19%	2,638 $32,000
Q2 2024 Jul 25, 2024	BUY	$11.03 - $17.52 $39,388 - $62,563	3,571 Added 308.91%	4,727 $63,000
Q1 2024 Apr 25, 2024	SELL	$4.12 - $14.17 $28,110 - $96,681	-6,823 Reduced 85.51%	1,156 $15,000
Q4 2023 Feb 02, 2024	BUY	$3.37 - $5.4 $17,854 - $28,609	5,298 Added 197.61%	7,979 $41,000
Q3 2023 Nov 01, 2023	SELL	$3.78 - $11.99 $180,963 - $574,009	-47,874 Reduced 94.7%	2,681 $10,000
Q2 2023 Aug 04, 2023	BUY	$7.93 - $13.82 $400,901 - $698,670	50,555 New	50,555 $537,000
Q4 2022 Feb 02, 2023	BUY	$7.07 - $15.69 $75,352 - $167,224	10,658 New	10,658 $98,000
Q2 2021 Aug 12, 2021	SELL	$30.53 - $41.09 $13,402 - $18,038	-439 Reduced 66.41%	222 $7,000
Q1 2021 Apr 26, 2021	BUY	$36.08 - $69.81 $23,848 - $46,144	661 New	661 $25,000
Q4 2020 Feb 02, 2021	SELL	$33.62 - $61.93 $40,411 - $74,439	-1,202 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$22.23 - $37.48 $16,272 - $27,435	732 Added 155.74%	1,202 $40,000
Q2 2020 Jul 13, 2020	BUY	$20.26 - $29.73 $1,965 - $2,883	97 Added 26.01%	470 $11,000
Q1 2020 Apr 29, 2020	BUY	$16.8 - $34.15 $6,266 - $12,737	373 New	373 $8,000

Others Institutions Holding STOK

# of Institutions

136

Shares Held

57.3M

Call Options Held

5.7K

Put Options Held

24.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $320M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Stoke Therapeutics, Inc. Transaction History